FDA Drug Ad Rulings Do Not Need To Rely On Consumer Survey Data – Troy
Executive Summary
FDA decisions on whether direct-to-consumer drug ads are false or misleading do not need to be backed with consumer comprehension data, Chief Counsel Daniel Troy said